Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oaktree Acquisition III Life Sciences Unit | OACCU | Apr 17, 2025 | 10.31 | 0.00 |
Oaktree Capital A Pref | OAK-A | Apr 17, 2025 | 20.52 | +1.48 |
Oaktree Capital Group B Pref | OAK-B | Apr 17, 2025 | 20.38 | +1.12 |
Oaktree Specialty | OCSL | Apr 17, 2025 | 14.35 | +2.65 |
Oatly ADR | OTLY | Apr 17, 2025 | 8.62 | +0.58 |
Oblong | OBLG | Apr 17, 2025 | 2.08 | -5.01 |
Occidental Petroleum | OXY | Apr 17, 2025 | 39.71 | +3.28 |
Ocean Biomedical | OCEA | Apr 17, 2025 | 0.04 | -3.94 |
Ocean Power Technologies | OPTT | Apr 17, 2025 | 0.40 | -1.45 |
Oceaneering International | OII | Apr 17, 2025 | 17.90 | +3.65 |
OceanFirst Financial | OCFC | Apr 17, 2025 | 15.75 | +0.45 |
OceanFirst Pref | OCFCP | Apr 17, 2025 | 25.33 | +0.04 |
OceanPal | OP | Apr 17, 2025 | 0.69 | -0.14 |
Ocugen | OCGN | Apr 17, 2025 | 0.68 | +4.01 |
Ocular Therapeutix | OCUL | Apr 17, 2025 | 7.31 | +1.95 |
Oculis | OCS | Apr 17, 2025 | 18.27 | +1.39 |
Oddity Tech | ODD | Apr 17, 2025 | 41.95 | +3.70 |
Odysight.ai | ODYS | Apr 17, 2025 | 5.35 | 0.00 |
Odyssey Marine Exploration | OMEX | Apr 17, 2025 | 0.56 | -18.86 |
Offerpad Solutions A | OPAD | Apr 17, 2025 | 1.48 | -1.33 |
Office Properties | OPI | Apr 17, 2025 | 0.36 | +12.17 |
OFG Bancorp | OFG | Apr 17, 2025 | 35.81 | +1.10 |
OFS Capital | OFS | Apr 17, 2025 | 8.44 | +3.56 |
OFS Credit | OCCI | Apr 17, 2025 | 6.44 | -2.57 |
OFS Credit C Pref | OCCIO | Apr 17, 2025 | 24.78 | 0.00 |
OFS Credit Company Pref F | OCCIM | Apr 17, 2025 | 24.39 | +0.45 |
OFS Credit E Pref | OCCIN | Apr 17, 2025 | 23.71 | -0.71 |
OGE Energy | OGE | Apr 17, 2025 | 45.10 | +0.89 |
Ohio Valley Bank | OVBC | Apr 17, 2025 | 35.50 | +11.46 |
Ohmyhome | OMH | Apr 17, 2025 | 2.96 | +54.16 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.